Anaveon appoints Dieter Weinand as Chair of its Board of Directors BASEL, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Dieter Weinand, former Chair and CEO of Bayer...

Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study